| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 05/31/2000 | CN1053013C Cloning and expression of microbial phytase |
| 05/31/2000 | CN1053012C Hog choera virus vaccine and diagnostic |
| 05/25/2000 | WO2000017233A3 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 05/23/2000 | US6066673 Enzyme inhibitors |
| 05/23/2000 | US6066503 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 05/23/2000 | US6066356 Genetic engineering; animal feeds; foods |
| 05/16/2000 | US6063614 Transformed fungal strains free of selection marker |
| 05/11/2000 | WO1999027100A9 Fibroblast growth factor-19 |
| 05/10/2000 | CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA |
| 05/04/2000 | WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | CA2017636C Derivative of tissue-type plasminogen activator |
| 04/26/2000 | CN1251531A Treatment of inner ear hair cells |
| 04/25/2000 | US6054294 Nucleic acid molecules encoding the neurotrophic factor NNT-1 |
| 04/20/2000 | WO2000022146A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 04/20/2000 | WO2000022099A1 Materials and methods for the modification of plant lignin content |
| 04/20/2000 | CA2344990A1 Materials and methods for the modification of plant lignin content |
| 04/20/2000 | CA2344711A1 Expression and secretion of icil-1 receptor antagonist type ii |
| 04/12/2000 | EP0992579A1 Stem cell factor |
| 04/12/2000 | EP0991766A1 Regulation of quinolate phosphoribosyl transferase expression |
| 04/12/2000 | EP0991761A1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 04/12/2000 | CN1250479A Modulators of the function of receptors of the TNF/NGF receptor family |
| 04/06/2000 | WO2000018885A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 04/06/2000 | CA2344653A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 04/05/2000 | CN1249780A CASH (caspase homologue) with death effector domain, modulators of function of FAS receptors |
| 04/05/2000 | CN1249433A NANBV diagnostics and vaccine |
| 04/04/2000 | US6046382 Plants with modified flowers |
| 03/30/2000 | WO2000017369A2 Alzheimer's disease secretase |
| 03/30/2000 | WO2000017320A2 Methods and reagents for inactivating ribonucleases |
| 03/30/2000 | WO2000017233A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 03/30/2000 | WO2000016746A2 Immunogenic liposome compositions |
| 03/30/2000 | WO1999060127A9 Il-17 homologous polypeptides and therapeutic uses thereof |
| 03/30/2000 | CA2360539A1 Methods and reagents for inactivating ribonucleases |
| 03/30/2000 | CA2343919A1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 03/30/2000 | CA2343324A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | CA2343004A1 Alzheimer's disease secretase |
| 03/28/2000 | CA2023094C Efficient production of mutant proteases |
| 03/23/2000 | WO1999046316A3 Enzyme inhibitors |
| 03/23/2000 | CA2343006A1 Compositions and methods for the treatment of immune related diseases |
| 03/23/2000 | CA2341767A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 03/23/2000 | CA2341304A1 Compositions and methods for the treatment of tumors |
| 03/15/2000 | EP0434721B1 Viral nucleotide sequences |
| 03/15/2000 | CN1050302C Chicken anaemia agent vaccine |
| 03/14/2000 | US6037322 Beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke; administered by continuous infusion |
| 03/14/2000 | US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma |
| 03/08/2000 | EP0983361A1 Bacterial pheromones and uses therefor |
| 03/08/2000 | EP0983344A1 Generation, characterization, and isolation of neuroepithelial stem cells and lineage restricted intermediate precursor |
| 03/08/2000 | CN1246800A Infectious bursits vaccine |
| 03/07/2000 | US6033908 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 03/02/2000 | WO2000011221A1 Method for determining polynucleotide sequence variations |
| 03/02/2000 | CA2336546A1 Method for determining polynucleotide sequence variations |
| 02/24/2000 | WO2000009689A2 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof |
| 02/24/2000 | WO2000009657A2 Methods of modulating of angiogenesis |
| 02/24/2000 | CA2340428A1 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof |
| 02/23/2000 | EP0980426A1 TYROSINE PHOSPHORYLATED CLEAVAGE FURROW-ASSOCIATED PROTEINS (PSTPIPs) |
| 02/23/2000 | CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B |
| 02/22/2000 | CA1340906C Fibronectin binding protein as well as its preparation |
| 02/17/2000 | WO2000001815A3 Neurotrophic factors |
| 02/09/2000 | EP0977842A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 02/08/2000 | US6022703 Expression of DNA sequences derived from nocardioform microorganisms |
| 02/03/2000 | WO1999060120A3 Soluble t cell receptor |
| 02/03/2000 | WO1999060119A3 Multivalent t cell receptor complexes |
| 02/02/2000 | EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA |
| 02/02/2000 | EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 02/01/2000 | CA2069085C Activatable fibrinolytic and anti-thrombotic proteins |
| 01/27/2000 | WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof |
| 01/26/2000 | EP0974655A2 G-CSF analog compositions and methods |
| 01/26/2000 | EP0973877A4 Improved support layer for enzyme electrode laminated membranes |
| 01/26/2000 | EP0973877A1 Improved support layer for enzyme electrode laminated membranes |
| 01/26/2000 | EP0643766B1 Improved mixture of nutrients for the bioremediation of polluted soils and waters |
| 01/26/2000 | CN1242803A Glyphosate resistant transgenic plants |
| 01/20/2000 | WO2000003014A1 Pharmaceutical uses of nab1 and nab2 |
| 01/20/2000 | CA2336805A1 Pharmaceutical uses of nab1 and nab2 |
| 01/19/2000 | EP0972033A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 01/18/2000 | US6015794 Trans-splicing ribozymes |
| 01/18/2000 | US6015572 Glial cells with neurotropic factors for nerve damage |
| 01/13/2000 | WO2000001815A2 Neurotrophic factors |
| 01/12/2000 | CN1240829A Optimization method for activation of endogenetic gene of cell |
| 01/05/2000 | EP0967991A1 Infectious bursitis vaccine |
| 01/04/2000 | US6010725 Containing microorgansims used as food additives |
| 12/29/1999 | WO1999067371A1 Enzyme stabilization by cationic surfactants |
| 12/28/1999 | US6008199 Continuously infusing an activated protein c for about 24 to 144 hours |
| 12/22/1999 | EP0965638A2 G-CSF analog compositions and methods |
| 12/21/1999 | US6005092 Arabidopsis thaliana endo-1,4-β-glucanase gene and promoter |
| 12/21/1999 | US6004813 Il-6 activity inhibitor |
| 12/14/1999 | US6001348 An nad (nicotinamide-adenine dinucleotide)-independent live attenuated strain of mycoplasma synoviae; and less expensive vaccines for protecting poultry against mycoplasma synoviae |
| 12/14/1999 | CA2155024C Genetic modification of neural stem cells |
| 12/14/1999 | CA2002890C Expression of dna sequences derived from nocardioform microorganisms |
| 12/14/1999 | CA1340852C Process for purifying primate gm-csf protein |
| 12/14/1999 | CA1340847C Adhesin antigens |
| 12/09/1999 | WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 12/08/1999 | CN1237980A Polypptides comprising GAX protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acid and their use |
| 12/07/1999 | US5998133 Use of genetic markers to diagnose familial dysautonomia |
| 11/30/1999 | US5994128 Primary cells containing a nucleic acid molecule from the adenovirus early genes, eia and eib; an encapsidating signal sequence and an inverted terminal repeat with no overlapping sequences with the target cells; autoimmune disease therapy |
| 11/25/1999 | WO1999060127A2 Il-17 homologous polypeptides and therapeutic uses thereof |
| 11/25/1999 | WO1999060120A2 Soluble t cell receptor |
| 11/25/1999 | WO1999060119A2 Multivalent t cell receptor complexes |
| 11/25/1999 | CA2328496A1 Il-17 homologous polypeptides and therapeutic uses thereof |
| 11/25/1999 | CA2328144A1 Multivalent t cell receptor complexes |